PFE Dec 2025 42.500 call
| Previous close | 0.4200 |
| Open | 0.4200 |
| Bid | 0.3600 |
| Ask | 0.5200 |
| Strike | 42.50 |
| Expiry date | 2025-12-19 |
| Day's range | 0.4200 - 0.4200 |
| Contract range | N/A |
| Volume | |
| Open interest | 782 |
Insider MonkeyPfizer. Inc. (PFE): One of the Best Affordable Stocks Under $40 According to Short Sellers
We recently compiled a list of the 10 Best Affordable Stocks Under $40 According to Short Sellers. In this article, we are going to take a look at where Pfizer. Inc. (NYSE:PFE) stands against the other affordable stocks under $40. Several traders tend to profit from stocks through appreciation. However, some do the opposite– their idea […]
Investor's Business DailyWhy IBD 50's Alnylam Just Reversed Its 50% Gain — And BridgeBio Surged
Alnylam stock tumbled Friday after the company's Pfizer-rivaling heart disease treatment lagged expectations in a lengthy study.
- Associated Press Finance
US clears updated COVID shots from Novavax, adding a 3rd fall vaccine option
U.S. regulators have cleared a third updated COVID-19 vaccine for this fall, shots made by Novavax Inc. Already, Pfizer and Moderna are shipping shots modified to better match more recent strains of the ever-evolving coronavirus. Friday, the Food and Drug Administration gave the OK to the updated Novavax formula, too — and those shots are open to anyone 12 and older.
